Biophytis (BPTS) News Today → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free BPTS Stock Alerts $10.19 +0.37 (+3.77%) (As of 04/23/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinemarketbeat.com - April 23 at 6:06 AMBiophytis (NASDAQ:BPTS) Shares to Reverse Split on Tuesday, April 23rdamericanbankingnews.com - April 19 at 1:22 AMBiotech Catches Major Premarket Bid Following Financial Resultstheglobeandmail.com - April 9 at 1:13 PMWhy Is Penny Stock Biophytis Trading Higher On Tuesday?finance.yahoo.com - April 9 at 1:13 PMWhy Is Biophytis (BPTS) Stock Up 43% Today?investorplace.com - April 9 at 8:00 AMBiophytis announces its 2023 financial results -2-finanznachrichten.de - April 8 at 8:10 PMResults of the Combined General Meeting on April 2, 2024finance.yahoo.com - April 4 at 5:43 PMEuropean Equities Traded in the US as American Depositary Receipts Slightly Higher in Friday Tradingmsn.com - March 22 at 7:12 PMEuropean Equities Traded in the US as American Depositary Receipts Flat in Tuesday Tradingmsn.com - March 19 at 2:16 PMEuropean Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Tradingmsn.com - March 12 at 1:14 PMEuropean Equities Traded in the US as American Depositary Receipts Edge Higher Wednesdaymsn.com - December 20 at 12:30 PMBiophytis and Innovation Solutions Pharma Sign a Partnership Agreement to Accelerate Market Access for Sarconeos (BIO101) in Brazilfinance.yahoo.com - October 30 at 1:27 AMBiophytis ADS Fall 8.5% in After Receiving Nasdaq Noticemarketwatch.com - October 27 at 7:53 PMBiophytis Receives Notice of Delisting From NASDAQ and Announces It Will Request a Hearing Before the NASDAQ Hearings Panelfinance.yahoo.com - October 27 at 7:53 PMBiophytis shares surge 41% following Covid partnership with France's Skyepharmaproactiveinvestors.com - September 29 at 11:08 PMBiophytis (BPTS) Soars 73% on Partnership With Skyepharmafinance.yahoo.com - September 26 at 12:45 PMWhy Biophytis (BPTS) Shares Are Sky-Rocketingbenzinga.com - September 25 at 3:20 PMBiophytis Shares Surge 79% Following Covid-19 Partnership With Skyepharmamarkets.businessinsider.com - September 25 at 3:20 PMmarketbeat.com - September 25 at 11:04 AMBiophytis Shares Rise 41% After Partnership Deal With Skyepharmamarketwatch.com - September 25 at 10:20 AMBiophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101)finance.yahoo.com - September 25 at 10:20 AMWhy Is Biophytis (BPTS) Stock Up 49% Today?msn.com - September 25 at 10:20 AMBiophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101)finance.yahoo.com - September 25 at 10:20 AMBiophytis Provides an Update on its Early Access Programs for Sarconeos in the Treatment of Severe Forms of COVID-19finanznachrichten.de - September 20 at 7:58 PMBiophytis Provides an Update on its Early Access Programs for Sarconeos (BIO101) in the Treatment of Severe Forms of COVID-19finance.yahoo.com - September 19 at 7:50 AMBiophytis Strengthens its Management Team with the Appointment of its Chief Business Officerfinance.yahoo.com - September 14 at 9:24 AMBiophytis Obtains FDA Authorization to Initiate the SARA-31 Phase 3 Study in Sarcopeniafinanznachrichten.de - September 11 at 2:53 AMBiophytis Obtains FDA Authorization to Initiate the SARA-31 Phase 3 Study in Sarcopeniafinance.yahoo.com - September 11 at 2:53 AMBiophytis to Participate at the H.C. Wainwright 25th Global Investment Conference in New Yorkfinance.yahoo.com - September 4 at 5:38 PMBiophytis Announces Next Regulatory Steps in Europe and the United States for its COVA Projectfinance.yahoo.com - August 16 at 2:28 AMWhy Is Biophytis (BPTS) Stock Up 18% Today?msn.com - August 8 at 9:33 AMBiophytis Receives a Positive Opinion for its SARA-31 Phase 3 Study in Sarcopenia in Europefinance.yahoo.com - August 8 at 9:33 AMBiophytis Shares Drop 11% After Request for Meeting With FDA on Covid-19 Treatmentmarketwatch.com - July 20 at 2:25 PMBiophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19finance.yahoo.com - July 20 at 9:25 AMBiophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19finance.yahoo.com - July 20 at 9:25 AMBiophytis Shares Drop 12% on Direct Offering Pricingmarketwatch.com - July 19 at 1:35 PMmarketbeat.com - July 19 at 10:09 AMBiophytis Announces USD3.8 Million Registered Direct Offeringfinanznachrichten.de - July 19 at 8:34 AMBiophytis Announces $3.8 Million Registered Direct Offeringfinance.yahoo.com - July 19 at 8:34 AMiCAD, Biophytis top healthcare gainers; Lixte, Masimo lead losers packseekingalpha.com - July 18 at 3:17 PMWhy Are Biophytis Shares Skyrocketing Today?benzinga.com - July 18 at 3:17 PMBiophytis and SEQENS will together produce Sarconeos active compoundmsn.com - July 18 at 10:17 AMBiophytis Reports Clinical Results for Sarconeos in Sarcopenia Treatment at the 16th SCWD International Congressfinanznachrichten.de - June 19 at 9:14 AMBiophytis Reports Clinical Results for Sarconeos (BIO101) in Sarcopenia Treatment at the 16th SCWD International Congressfinance.yahoo.com - June 19 at 9:14 AMBiophytis: Results of the Annual General Meeting on June 16, 2023 All Resolutions Presented by the Company Have Been Adoptedfinance.yahoo.com - June 16 at 7:02 PMBiophytis to Participate at the BIO International Convention in Boston from the 5th to the 8th of Junefinance.yahoo.com - June 5 at 8:37 AMBiophytis has Filed with the French National Authority for Health (HAS) an Application for Early Access Authorisation (EAA) for Sarconeos (BIO101) in the Treatment of Severe Forms of COVID-19finance.yahoo.com - May 26 at 5:15 AMBiophytis ticks higher after presenting COVID drug data at conferencemsn.com - May 25 at 9:13 AMBiophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conferencefinance.yahoo.com - May 25 at 9:13 AMSuccessful Capital Increase for Biophytis with EUR2.3 million Raisedmarketwatch.com - May 11 at 6:48 PM Get Biophytis News Delivered to You Automatically Sign up to receive the latest news and ratings for BPTS and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better. Click here to find out that this 8,788% cryptocurrency is. BPTS Media Mentions By Week BPTS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPTS News Sentiment▼0.220.46▲Average Medical News Sentiment BPTS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPTS Articles This Week▼21▲BPTS Articles Average Week Get Biophytis News Delivered to You Automatically Sign up to receive the latest news and ratings for BPTS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VRPX News Today CING News Today EVOK News Today KTRA News Today THAR News Today MBIO News Today ZVSA News Today PCSA News Today GNPX News Today NEXI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BPTS) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biophytis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
